Clonidine in the treatment of mania and mixed bipolar disorder. 1984

G S Zubenko, and B M Cohen, and J F Lipinski, and J M Jonas

The symptoms of three bipolar patients remitted after clonidine treatment. One patient presented with mixed bipolar disorder, two were manic, and all were psychotic. One patient's akathisia also appeared to respond to clonidine. Clonidine's thymoleptic effect paralleled resulting cardiovascular changes.

UI MeSH Term Description Entries
D008297 Male Males
D011595 Psychomotor Agitation A feeling of restlessness associated with increased motor activity. This may occur as a manifestation of nervous system drug toxicity or other conditions. Agitation, Psychomotor,Akathisia,Excitement, Psychomotor,Restlessness,Psychomotor Hyperactivity,Psychomotor Restlessness,Hyperactivity, Psychomotor,Psychomotor Excitement,Restlessness, Psychomotor
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive

Related Publications

G S Zubenko, and B M Cohen, and J F Lipinski, and J M Jonas
January 1989, Acta psychiatrica Scandinavica,
G S Zubenko, and B M Cohen, and J F Lipinski, and J M Jonas
March 2023, Brain sciences,
G S Zubenko, and B M Cohen, and J F Lipinski, and J M Jonas
August 1999, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
G S Zubenko, and B M Cohen, and J F Lipinski, and J M Jonas
December 2007, Neuropsychiatric disease and treatment,
G S Zubenko, and B M Cohen, and J F Lipinski, and J M Jonas
November 2006, CNS spectrums,
G S Zubenko, and B M Cohen, and J F Lipinski, and J M Jonas
October 2004, Discovery medicine,
G S Zubenko, and B M Cohen, and J F Lipinski, and J M Jonas
March 2017, The primary care companion for CNS disorders,
G S Zubenko, and B M Cohen, and J F Lipinski, and J M Jonas
April 2017, Current neuropharmacology,
G S Zubenko, and B M Cohen, and J F Lipinski, and J M Jonas
April 1995, American family physician,
Copied contents to your clipboard!